Hilary J. Goldberg

Dr. Hilary J. Goldberg


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
AEAnthony J. Esposito
Anthony J. Esposito
AMAravind A. Menon
Aravind A. Menon
AGAuyon J. Ghosh
Auyon J. Ghosh
RPRachel K. Putman
Rachel K. Putman
LFLaura E. Fredenburgh
Laura E. Fredenburgh
TDTracy J. Doyle
Tracy J. Doyle

7 March 2017 in Respiratory Research
Verified
Journal Article
Open access
PDF file
SASamuel Y. Ash
Samuel Y. Ash
RHRola Harmouche
Rola Harmouche
DVDiego Lassala Lopez Vallejo
Diego Lassala Lopez Vallejo
JVJulian A. Villalba
Julian A. Villalba
KOKris Ostridge
Kris Ostridge
GWGeorge R. Washko
George R. Washko
Prior studies of clinical prognostication in idiopathic pulmonary fibrosis (IPF) using computed tomography (CT) have often used subjective analyses or have evaluated quantitative measures in isolation. This study examined associations between both densitometric and local histogram based quantitative CT measurements with pulmonary function test (PFT) parameters and mortality. In addition, this study sought to compare risk prediction scores that incorporate quantitative CT measures with previously described systems. Forty six patients with biopsy proven IPF were identified from a registry of patients with interstitial lung disease at Brigham and Women’s Hospital in Boston, MA. CT scans for each subject were visually scored using a previously published method. After a semi-automated method was used to segment the lungs from the surrounding tissue, densitometric measurements including the percent high attenuating area, mean lung density, skewness and kurtosis were made for the entirety of each patient’s lungs. A separate, automated tool was used to detect and quantify the percent of lung occupied by interstitial lung features. These analyses were used to create clinical and quantitative CT based risk prediction scores, and the performance of these was compared to the performance of clinical and visual analysis based methods. All of the densitometric measures were correlated with forced vital capacity and diffusing capacity, as were the total amount of interstitial change and the percentage of interstitial change that was honeycombing measured using the local histogram method. Higher percent high attenuating area, higher mean lung density, lower skewness, lower kurtosis and a higher percentage of honeycombing were associated with worse transplant free survival. The quantitative CT based risk prediction scores performed similarly to the clinical and visual analysis based methods. Both densitometric and feature based quantitative CT measures correlate with pulmonary function test measures and are associated with transplant free survival. These objective measures may be useful for identifying high risk patients and monitoring disease progression. Further work will be needed to validate these measures and the quantitative imaging based risk prediction scores in other cohorts.

1 July 2017 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
ACAndrew M. Courtwright
Andrew M. Courtwright
SESouheil El-Chemaly
Souheil El-Chemaly
PDPaul F. Dellaripa
Paul F. Dellaripa
HGHilary J. Goldberg
Hilary J. Goldberg

1 November 2006 in Respiratory Medicine
Verified
Journal Article
Closed access
HGHilary J. Goldberg
Hilary J. Goldberg
DFDouglas Fiedler
Douglas Fiedler
AWAmy Webb
Amy Webb
JJJashiree Jagirdar
Jashiree Jagirdar
AHAnastacio M. Hoyumpa
Anastacio M. Hoyumpa
JPJay Peters
Jay Peters

1 March 2018 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
AMAnna Moniodis
Anna Moniodis
KTKeri Townsend
Keri Townsend
ARAlexander Rabin
Alexander Rabin
OAObadah Aloum
Obadah Aloum
JSJessica Stempel
Jessica Stempel
HGHilary J. Goldberg
Hilary J. Goldberg

1 September 2019 in Annals of the American Thoracic Society
Verified
Journal Article
Closed access
ACAndrew M. Courtwright
Andrew M. Courtwright
SCSeverine Cao
Severine Cao
IWIsabelle Wood
Isabelle Wood
HMHari R. Mallidi
Hari R. Mallidi
JKJared Kawasawa
Jared Kawasawa
HGHilary J. Goldberg
Hilary J. Goldberg
Rationale: There is significant variation in approach to pre–lung transplant donor-specific antibodies (DSA), with some centers declining to cross any DSA. We implemented a protocol for transplantation for candidates with pretransplant DSA so long as a prospective complement-dependent cytotoxicity crossmatch was negative, regardless of number, specificity, class, or mean fluorescence intensity. Objectives: To compare post-transplant outcomes including overall survival, chronic lung allograft dysfunction–free survival, antibody-mediated rejection, and acute cellular rejection in lung transplant recipients where pretransplant DSA was and was not present. Methods: This was a single-center retrospective cohort study. For recipients with pretransplant DSA, if the prospective complement-dependent cytotoxicity crossmatch was negative, the donor offer was accepted and plasmapheresis was performed within 24 hours of transplantation and continued until retrospective crossmatch results returned. Immunosuppression and post-transplant management were not otherwise modified. Results: Of the 203 included recipients, 18 (8.9%) had pretransplant DSA. The median DSA mean fluorescence intensity was 4,000 (interquartile range, 2,975–5,625; total range, 2,100–17,000). The median number of DSA present per patient was one (interquartile range, 1–2). The presence of pretransplant DSA was not associated with increased mortality (hazard ratio, 1.2; 95% confidence interval [CI], 0.4–3.4) or decreased chronic lung allograft dysfunction–free survival (hazard ratio, 1.1; 95% CI, 0.6–2.1). Recipients with pretransplant DSA were more likely to require prolonged mechanical ventilation (adjusted odds ratio, 7.0; 95% CI, 2.3–21.6) and to have antibody-mediated rejection requiring treatment (adjusted odds ratio, 7.5; 95% CI, 1.0–55.8). Conclusions: A protocol of accepting donor offers for lung transplant candidates with preformed, complement-dependent cytotoxicity crossmatch-negative DSA is associated with increased need for prolonged mechanical ventilation and antibody-mediated rejection without affecting short-term overall or chronic lung allograft dysfunction–free survival.